US15117B2025 - CLDX - A2PEAB (XNCM)
CELLDEX THERAPEUTICSCS INC Aktie
40,70 USD
Aktuelle Kurse von CELLDEX THERAPEUTICSCS INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
CLDX
|
USD
|
20.09.2024 21:12
|
40,70 USD
| 41,16 USD | -1,13 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
-1,13 % | -6,15 % | 17,24 % | 17,41 % | 0,51 % | 52,93 % | 1.521,31 % |
Firmenprofil zu CELLDEX THERAPEUTICSCS INC Aktie
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. The company has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. Celldex Therapeutics, Inc. was incorporated in 1983 and is headquartered in Hampton, New Jersey.
Unternehmensdaten zur CELLDEX THERAPEUTICSCS INC Aktie
Name CELLDEX THERAPEUTICSCS INC
Firma Celldex Therapeutics, Inc.
Symbol CLDX
Website https://www.celldex.com
Heimatbörse
NASDAQ CAPITAL MARKET
WKN A2PEAB
ISIN US15117B2025
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. Anthony S. Marucci M.B.A.
Marktkapitalisierung 3 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,2 T
Adresse Perryville III Building, 08827 Hampton
IPO Datum 1986-05-15
Aktien-Splits
Datum | Split |
---|---|
11.02.2019 | 1:15 |
10.03.2008 | 1:12 |
10.03.2007 | 1:1 |
Aktien Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
29.09.2008 | AVAN | CLDX |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | TCE2.F |
NASDAQ | CLDX |
Weitere Aktien
Investoren die CELLDEX THERAPEUTICSCS INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024